BIOSPECIFICS TECHNOLOGIES CORP (29) | Business Operations (2)
- At-The-Market Equity Offering Sales Agreement, dated August 31, 2020, among the Company, Stifel, Nicolaus & Company, Incorporated and Oppenheimer & Co. Inc (Filed With SEC on August 31, 2020)
- Amended and Restated Indemnification Agreement, dated September 12, 2012, by and between the Company and Patrick M. Caldwell (Filed With SEC on April 2, 2019)